{"url":"https://lda.gov/api/v1/filings/7695bc6b-4146-4790-93a1-5b0440fdc4cf/","filing_uuid":"7695bc6b-4146-4790-93a1-5b0440fdc4cf","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7695bc6b-4146-4790-93a1-5b0440fdc4cf/print/","filing_document_content_type":"text/html","income":null,"expenses":"380000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Amanda Pezalla","dt_posted":"2026-07-19T17:06:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"211 Mt Airy Rd","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Basking Ridge","registrant_state":"NJ","registrant_zip":"07920","registrant":{"id":316731,"url":"https://lda.gov/api/v1/registrants/316731/","house_registrant_id":39286,"name":"DAIICHI SANKYO, INC.","description":null,"address_1":"211 Mt Airy Rd","address_2":null,"address_3":null,"address_4":null,"city":"Basking Ridge","state":"NJ","state_display":"New Jersey","zip":"07920","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMANDA PEZALLA","contact_telephone":"+1 202-223-6572","dt_updated":"2026-07-29T22:42:31.603206-04:00"},"client":{"id":185884,"url":"https://lda.gov/api/v1/clients/185884/","client_id":12,"name":"DAIICHI SANKYO INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions related to the Protecting Patient Access to Cancer and Complex Therapies Act reintroduction Issues related to most-favored-nation and other foreign reference drug pricing policy Issues related to the Food and Drug Administration Issues regarding 340B program","foreign_entity_issues":"To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.","lobbyists":[{"lobbyist":{"id":145079,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"PEZALLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153737,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154398,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"VEATCH","suffix":null,"suffix_display":null},"covered_position":"DHS Counsel/Policy 2020-2021;Legislative Counsel, US House 2017-2020","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Discussions regarding tax reform and tariffs","foreign_entity_issues":"To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.","lobbyists":[{"lobbyist":{"id":145079,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"PEZALLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153737,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154398,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"VEATCH","suffix":null,"suffix_display":null},"covered_position":"DHS Counsel/Policy 2020-2021;Legislative Counsel, US House 2017-2020","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to the Medicare Drug Price Negotiation Program Issues regarding the GLOBE model","foreign_entity_issues":"To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.","lobbyists":[{"lobbyist":{"id":145079,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"PEZALLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153737,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154398,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"VEATCH","suffix":null,"suffix_display":null},"covered_position":"DHS Counsel/Policy 2020-2021;Legislative Counsel, US House 2017-2020","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to intellectual property rights","foreign_entity_issues":"To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.","lobbyists":[{"lobbyist":{"id":145079,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"PEZALLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153737,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154398,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"VEATCH","suffix":null,"suffix_display":null},"covered_position":"DHS Counsel/Policy 2020-2021;Legislative Counsel, US House 2017-2020","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}